Justin D. Gover, Chief Executive Officer at GW PHARMACEUTICALS PLC (GWPH), sold 21,480 shares at $9.01 ($194K) on 2020-02-26, disclosed to the SEC on 2020-02-28.
Open-market sale of $194k GWPH by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.01 | 9,480 | $85K | 44.0% |
| 2 | $9.01 | 9,480 | $85K | 44.0% |
| 3 | $9.17 | 1,644 | $15K | 7.8% |
| 4 | $9.21 | 876 | $8K | 4.2% |
| Total | $9.03 avg | 21,480 | $194K | 100% |
| Filing → |
| GWPH | SELL | 2020-03-04 | $477K | — | Filing → |
| GWPH | SELL | 2020-02-05 | $3.9M | — | Filing → |
| GWPH | SELL | 2019-12-19 | $49K | — | Filing → |